Bio Usawa is proud to celebrate its Scientific Advisory Board Member, Dr. Nazik Hammad, MD, MSc, MEHP, FACP for receiving the Conquer Cancer (The ASCO Foundation)’s International Women Who Conquer Cancer Mentorship Award at this year’s annual ASCO meeting in Chicago, IL. Conquer Cancer’s grants and awards, totaling more than $11.5 MUSD this year, support oncology professionals at every career stage to help accelerate breakthroughs in research across the globe. Dr. Hammad, an internationally known oncologist specializing in breast and GI cancers at University of Toronto’s St. Michael Hospital, received the Mentorship award in recognition of her tireless contributions to faculty and workforce development in Africa. She is also Chair of the African Organization for Research and Training in Cancer (AORTIC) Significant Interest Group in Cancer in Conflict Zones and other Humanitarian settings. Congratulations, Dr. Hammad!
Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond.
Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.
Bio Usawa Biotechnology Ltd. (Bio Usawa) and Bioeq AG today announced a groundbreaking agreement that will bring a life-changing biosimilar medicine—ran…
July 2025Dr. Menghis Bairu, CEO, Co-Founder and President of Bio Usawa (BUI), together with Dr. Miriam Mutebi, internationally recognized surgical oncologist and…
June 2025Eric Karikari – Boateng, MSc, Head of Global Regulatory Strategy at Bio Usawa (BUI), and Elise Brownell, PhD, Chief of Staff, lead the Company’s Executi…
June 2025